» Articles » PMID: 37765290

Natural Bioactive Compounds from Marine Invertebrates That Modulate Key Targets Implicated in the Onset of Type 2 Diabetes Mellitus (T2DM) and Its Complications

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2023 Sep 28
PMID 37765290
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Type 2 diabetes mellitus (T2DM) is an ongoing, risky, and costly health problem that therefore always requires new treatment options. Moreover, although several drugs are available, only 36% of patients achieve glycaemic control, and patient adherence is a major obstacle. With monotherapy, T2DM and its comorbidities/complications often cannot be managed, and the concurrent administration of several hypoglycaemic drugs is required, which increases the risk of side effects. In fact, despite the efficacy of the drugs currently on the market, they generally come with serious side effects. Therefore, scientific research must always be active in the discovery of new therapeutic agents.

Discussion: The present review highlights some of the recent discoveries regarding marine natural products that can modulate the various targets that have been identified as crucial in the establishment of T2DM disease and its complications, with a focus on the compounds isolated from marine invertebrates. The activities of these metabolites are illustrated and discussed.

Objectives: The paper aims to capture the relevant evidence of the great chemical diversity of marine natural products as a key tool that can advance understanding in the T2DM research field, as well as in antidiabetic drug discovery. The variety of chemical scaffolds highlighted by the natural hits provides not only a source of chemical probes for the study of specific targets involved in the onset of T2DM, but is also a helpful tool for the development of drugs that are capable of acting via novel mechanisms. Thus, it lays the foundation for the design of multiple ligands that can overcome the drawbacks of polypharmacology.

Citing Articles

Identification of Antioxidant Methyl Derivatives of -Carbonyl Hydroquinones That Reduce Caco-2 Cell Energetic Metabolism and Alpha-Glucosidase Activity.

Monroy-Cardenas M, Almarza C, Valenzuela-Hormazabal P, Ramirez D, Urra F, Martinez-Cifuentes M Int J Mol Sci. 2024; 25(15).

PMID: 39125904 PMC: 11313435. DOI: 10.3390/ijms25158334.


Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes.

Giuliani M, Bigossi G, Lai G, Marcozzi S, Brunetti D, Malavolta M Mar Drugs. 2024; 22(5).

PMID: 38786601 PMC: 11123485. DOI: 10.3390/md22050210.


Searching for Novel Sources of Hydrogen Sulfide Donors: Chemical Profiling of Extract and Evaluation of the Anti-Inflammatory Effects.

Casertano M, Esposito E, Bello I, Indolfi C, Putra M, Di Cesare Mannelli L Mar Drugs. 2023; 21(12).

PMID: 38132963 PMC: 10744941. DOI: 10.3390/md21120641.

References
1.
Ye F, Zhu Z, Gu Y, Li J, Zhu W, Guo Y . Further New Diterpenoids as PTP1B Inhibitors from the Xisha Soft Coral Sinularia polydactyla. Mar Drugs. 2018; 16(4). PMC: 5923390. DOI: 10.3390/md16040103. View

2.
Roberts C, Hevener A, Barnard R . Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013; 3(1):1-58. PMC: 4129661. DOI: 10.1002/cphy.c110062. View

3.
Thakur S, Gupta S, Ali V, Singh P, Verma M . Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. Arch Pharm Res. 2021; 44(7):655-667. DOI: 10.1007/s12272-021-01343-5. View

4.
Carroll A, Copp B, Davis R, Keyzers R, Prinsep M . Marine natural products. Nat Prod Rep. 2023; 40(2):275-325. DOI: 10.1039/d2np00083k. View

5.
Kaur R, Dahiya L, Kumar M . Fructose-1,6-bisphosphatase inhibitors: A new valid approach for management of type 2 diabetes mellitus. Eur J Med Chem. 2017; 141:473-505. DOI: 10.1016/j.ejmech.2017.09.029. View